IJCM  Vol.6 No.9 , September 2015
Obesity in Hemodialysis Patients
ABSTRACT
Obesity is a cardiovascular risk factor in the general population. However, obesity on hemodialysis is associated with better survival. The aim of this study is to determine the prevalence of obesity in our chronic hemodialysis population and to specify the different cardiovascular complications. It is a cross-sectional study with 120 patients older than 18 years on hemodialysis. Abdominal obesity was defined as waist circumference > 94 cm in men and > 80 cm in women. The following were analyzed: socioeconomic and demographic parameters, life , initial renal disease, duration of hemodialysis, food consumption and body mass index (BMI), biological parameters (C-reactive protein (CRP), albumin, lipid profiles, serum calcium, phosphorus, parathyroid hormone), comorbidities: Diabetes, hypertension, stroke, coronary artery disease. Twenty-four patients had a BMI> 25. The prevalence of abdominal obesity was 20%. The sex Ratio was 0.71. The average age of our patients was 55.97 years [23 - 78 years]. Reduced physical activity was observed in 75% of patients. Duration in hemodialysis was 79 months. Hemoglobin (Hb) average was 8.9 g/dl, serum calcium was 2.25 mmol/l, serum phosphorus was 1.7 mmol/l, parathyroid hormone (PTH) was 412 pg/ml, albuminemia was 30.7 g/l, total cholesterol was 3.75 mmol/l and CRP was 15 U/l. Coronary artery disease was found in 20.8% of cases, stroke in 8.3% of cases, diabetes in 58.33% of cases and hypertension in 75% of cases. There was a high prevalence of abdominal obesity in hemodialysis patients. Obesity is recognized by its association with increased risk of cardiovascular disease and mortality. However in the paradoxical epidemiology, obesity becomes in chronic hemodialysis, a protective factor and is associated with better survival. Our study has a small population and cannot reach such a conclusion; further studies with larger numbers are needed to support this concept.

Cite this paper
Gorsane, I. , Mahfoudhi, M. , El Euch, M. , Younsi, F. and Abdallah, T. (2015) Obesity in Hemodialysis Patients. International Journal of Clinical Medicine, 6, 667-671. doi: 10.4236/ijcm.2015.69089.
References
[1]   Freitas, A.T., Vaz, I.M., Ferraz, S.F., Peixoto Mdo, R., Campos, M.I. and Fornés, N.S. (2013) Prevalence and Associated Factors with Abdominal Obesity in Hemodialysis Patients in Goiania—GO. Jornal Brasileiro de Nefrologia, 35, 265-272.
http://dx.doi.org/10.5935/0101-2800.20130045

[2]   Yang, S.Y., Chiang, C.K., Hsu, S.P., Peng, Y.S., Pai, M.F., Ho, T.I., et al. (2007) Metabolic Syndrome Predicts Hospitalization in Hemodialysis Patients: A Prospective Asian Cohort Study. Blood Purification, 25, 252-259.
http://dx.doi.org/10.1159/000101698

[3]   Panzetta, G. and Abaterusso, C. (2010) Obesity in Dialysis and Reverse Epidemiology: True or False? Giornale Italiano di Nefrologia, 27, 629-638.

[4]   Furman-Niedziejko, A., Rostoff, P., Rychlak, R., Golinska-Grzybala, K., Wilczynska-Golonka, M., Golonka, M., et al. (2014) Relationship between Abdominal Obesity, Platelet Blood Count and Mean Platelet Volume in Patients with Metabolic Syndrome. Folia Medica Cracoviensia, 54, 55-64.

[5]   Berg, A.H. and Scherer, P.E. (2005) Adipose Tissue, Inflammation, and Cardiovascular Disease. Circulation Research, 96, 939-949.
http://dx.doi.org/10.1161/01.RES.0000163635.62927.34

[6]   Honda, H., Qureshi, A.R., Axelsson, J., Heimburger, O., Suliman, M.E., Barany, P., et al. (2007) Obese Sarcopenia in Patients with End-Stage Renal Disease Is Associated with Inflammation and Increased Mortality. The American Journal of Clinical Nutrition, 86, 633-638.

[7]   Axelsson, J., Rashid Qureshi, A., Suliman, M.E., Honda, H., Pecoits-Filho, R., et al. (2004) Fat Mass as a Contributor to Inflammation in End-Stage Renal Disease. The American Journal of Clinical Nutrition, 80, 1222-1229.

[8]   Gohda, T., Gotoh, H., Tanimoto, M., Sato, M., Io, H., Kaneko, K., et al. (2008) Relationship between Abdominal Fat Accumulation and Insulin Resistance in Hemodialysis Patients. Hypertension Research, 31, 83-88.
http://dx.doi.org/10.1291/hypres.31.83

[9]   Witasp, A., Carrero, J.J., Hammarqvist, F., Qureshi, A.R., Heimbürger, O., Schalling, M., et al. (2011) Expression of Osteoprotegerin in Human Fat Tissue; Implications for Chronic Kidney Disease. European Journal of Clinical Investigation, 4, 498-506.
http://dx.doi.org/10.1111/j.1365-2362.2010.02432.x

[10]   Kamimura, M.A., Carrero, J.J., Canziani, M.E., Watanabe, R., Lemos, M.M. and Cuppari, L. (2013) Visceral Obesity Assessed by Computed Tomography Predicts Cardiovascular Events in Chronic Kidney Disease Patients. Nutrition, Metabolism and Cardiovascular Diseases, 23, 891-897.
http://dx.doi.org/10.1016/j.numecd.2012.06.004

[11]   Postorino, M., Marino, C., Tripepi, G. and Zoccali, C., CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group (2009) Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease. Journal of the American College of Cardiology, 53, 1265-1272.
http://dx.doi.org/10.1016/j.jacc.2008.12.040

[12]   Wu, C.C., Liou, H.H., Su, P.F., Chang, M.Y., Wang, H.H., Chen, M.J., et al. (2011) Abdominal Obesity Is the Most Significant Metabolic Syndrome Component Predictive of Cardiovascular Events in Chronic Hemodialysis Patients. Nephrology Dialysis Transplantation, 26, 3689-3695.
http://dx.doi.org/10.1093/ndt/gfr057

[13]   Huang, J.W., Yang, C.Y., Wu, H.Y., Liu, K.L., Su, C.T., Wu, C.K., et al. (2013) Metabolic Syndrome and Abdominal Fat Are Associated with Inflammation, But Not with Clinical Outcomes, in Peritoneal Dialysis Patients. Cardiovascular Diabetology, 12, 86.
http://dx.doi.org/10.1186/1475-2840-12-86

[14]   Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
http://dx.doi.org/10.1001/jama.285.19.2486

[15]   Ucar, E., Huzmeli, C., Guven, O., Savas, N., Gullu, M., Asilyoruk, S., et al. (2009) Frequency of Metabolic Syndrome among Hemodialysis Patients According to NCEP-ATP III and IDF Definitions. Ren Fail, 31, 221-228.
http://dx.doi.org/10.1080/08860220802669883

[16]   Asicioglu, E., Kahveci, A., Arikan, H., Koc, M., Tuglular, S. and Ozener, C.I. (2013) Waist Circumference Is Associated with Carotid Intima Media Thickness in Peritoneal Dialysis Patients. International Urology and Nephrology, 45, 1437-1443.
http://dx.doi.org/10.1007/s11255-013-0427-x

[17]   Hung, P.H., Tsai, H.B., Lin, C.H. and Hung, K.Y. (2013) Abdominal Obesity Is Associated with Peripheral Artery Disease in Hemodialysis Patients. PLoS One, 8, e67555.
http://dx.doi.org/10.1371/journal.pone.0067555

[18]   Carrero, J.J., Stenvinkel, P., Cuppari, L., Ikizler, T.A., Kalantar-Zadeh, K., Kaysen, G., et al. (2013) Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM). Journal of Renal Nutrition, 23, 77-90.
http://dx.doi.org/10.1053/j.jrn.2013.01.001

[19]   Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., et al. (2008) A Proposed Nomenclature and Diagnostic Criteria for Protein-Energy Wasting in Acute and Chronic Kidney Disease. Kidney International, 73, 391-398.
http://dx.doi.org/10.1038/sj.ki.5002585

[20]   Postorino, M., Marino, C., Tripepi, G. and Zoccali, C. (2011) Abdominal Obesity Modifies the Risk of Hypertriglyceridemia for All-Cause and Cardiovascular Mortality in Hemodialysis Patients. Kidney International, 79, 765-772.
http://dx.doi.org/10.1038/ki.2010.493

[21]   Zoccali, C., Postorino, M., Marino, C., Pizzini, P., Cutrupi, S. and Tripepi, G. (2011) Waist Circumference Modifies the Relationship between the Adipose Tissue Cytokines Leptin and Adiponectin and All-Cause and Cardiovascular Mortality in Haemodialysis Patients. Journal of Internal Medicine, 269, 172-181.
http://dx.doi.org/10.1111/j.1365-2796.2010.02288.x

[22]   Carrero, J.J., Cordeiro, A.C., Lindholm, B. and Stenvinkel, P. (2010) The Emerging Pleiotrophic Role of Adipokines in the Uremic Phenotype. Current Opinion in Nephrology & Hypertension, 19, 37-42.
http://dx.doi.org/10.1097/MNH.0b013e328332fc2b

[23]   Witasp, A., Carrero, J.J., Heimbürger, O., Lindholm, B., Hammarqvist, F., Stenvinkel, P., et al. (2011) Increased Expression of Pro-Inflammatory Genes in Abdominal Subcutaneous Fat in Advanced Chronic Kidney Disease Patients. Journal of Internal Medicine, 269, 410-419.
http://dx.doi.org/10.1111/j.1365-2796.2010.02293.x

[24]   Carvalho, L.K., Silva, M.I.B., da Silva Vale, B., Bregman, R., Martucci, R.B., Carrero, J.J. and Avesani, C.M. (2012) Annual Variation in Body Fat Is Associated with Systemic Inflammation in Chronic Kidney Disease Patients Stages 3 and 4: A Longitudinal Study. Nephrology Dialysis Transplantation, 27, 1423-1428.
http://dx.doi.org/10.1093/ndt/gfr450

 
 
Top